Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02365376
Recruitment Status : Unknown
Verified February 2015 by BioMarin Pharmaceutical.
Recruitment status was:  Recruiting
First Posted : February 18, 2015
Last Update Posted : February 18, 2015
Sponsor:
Information provided by (Responsible Party):
BioMarin Pharmaceutical

Brief Summary:
The objective of this protocol is to enable collection of biospecimens to facilitate current and future multidisciplinary research in rare genetic disorders and medical conditions.

Condition or disease
Rare Genetic Disorders

Layout table for study information
Study Type : Observational
Observational Model: Case-Only
Official Title: Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions
Study Start Date : June 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rare Diseases




Primary Outcome Measures :
  1. continuous collection of donated study subject samples [ Time Frame: unknown, continuous sample collection ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals diagnosed with rare genetic diseases or medical conditions actively being investigated by BioMarin.
Criteria

Inclusion Criteria:

  • Willing and able to provide written, signed informed consent
  • Willing and able to comply with all study procedures

Exclusion Criteria:

  • Use of any investigational product or investigational medical device within 30 days prior to screening, except as part of a BioMarin-sponsored study
  • Concurrent disease or condition that would interfere with study participation or safety.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02365376


Contacts
Layout table for location contacts
Contact: Evelyn Wang 415-506-6818 EWang@bmrn.com

Locations
Layout table for location information
United States, Illinois
Lurie Children's Hospital of Chicago Recruiting
Chicago, Illinois, United States
Sponsors and Collaborators
BioMarin Pharmaceutical

Layout table for additonal information
Responsible Party: BioMarin Pharmaceutical
ClinicalTrials.gov Identifier: NCT02365376     History of Changes
Other Study ID Numbers: BMN 000-901
First Posted: February 18, 2015    Key Record Dates
Last Update Posted: February 18, 2015
Last Verified: February 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Genetic Diseases, Inborn
Rare Diseases
Disease Attributes
Pathologic Processes